[1] |
JIANG Xiaoqing, LI Zixiao, WANG Yongjun.
Progress in Clinical Research of Medical Quality Improvement in Stroke
[J]. Chinese Journal of Stroke, 2024, 19(2): 227-234.
|
[2] |
YANG Xin, ZHANG Jing, LI Zixiao, WANG Yongjun.
Construction and Development of Quality Control Indicator System for Single Disease
[J]. Chinese Journal of Stroke, 2024, 19(1): 22-27.
|
[3] |
YANG Xin, LI Zixiao, WANG Yongjun.
Revision Process of Medical Quality Control Indicators in Cerebral Infarction
[J]. Chinese Journal of Stroke, 2024, 19(1): 29-34.
|
[4] |
The Cerebrovascular Disease Working Group of National Center for Healthcare Quality Management in Neurological Diseases.
Medical Quality Control Indicators for Cerebral Infarction (2020 Edition)
[J]. Chinese Journal of Stroke, 2024, 19(1): 35-43.
|
[5] |
The Cerebrovascular Disease Working Group of National Center for Healthcare Quality Management in Neurological Diseases.
Medical Quality Control Indicators for Intracerebral Hemorrhage
[J]. Chinese Journal of Stroke, 2024, 19(1): 44-49.
|
[6] |
WANG Jing, LI Zixiao, DONG Qiang, ZHAO Xingquan.
Interpretation of Medical Quality Control Indicators for Intracerebral Hemorrhage
[J]. Chinese Journal of Stroke, 2024, 19(1): 50-54.
|
[7] |
LU Lu, XIONG Weixi, ZHOU Dong.
The Construction of the Medical Quality Control System for Epilepsy and Convulsive Status Epilepticus
[J]. Chinese Journal of Stroke, 2024, 19(1): 55-57.
|
[8] |
The Epilepsy Working Group of National Center for Healthcare Quality Management in Neurological Diseases.
Medical Quality Control Indicators for Epilepsy and Convulsive Status Epilepticus
[J]. Chinese Journal of Stroke, 2024, 19(1): 58-65.
|
[9] |
HE Ji, FAN Dongsheng.
Establish a Medical Standard and Continuous Quality Improvement System for Motor Neuron Disease in China
[J]. Chinese Journal of Stroke, 2024, 19(1): 66-68.
|
[10] |
The Motor Neuron Disease Working Group of National Center for Healthcare Quality Management in Neurological Diseases.
Medical Quality Control Indicators for Amyotrophic Lateral Sclerosis
[J]. Chinese Journal of Stroke, 2024, 19(1): 69-75.
|
[11] |
XU Yuming.
Stroke Center Construction and Quality Control: A Long Way to Go
[J]. Chinese Journal of Stroke, 2023, 18(9): 973-977.
|
[12] |
GAO Yuan, LIU Kai, LI Yapeng, YANG Zongyu, LI Yusheng, SONG Bo, XU Yuming.
Research Progress of the Construction and Quality Control of Stroke Center
[J]. Chinese Journal of Stroke, 2023, 18(9): 979-985.
|
[13] |
ZHANG Qian, JI Ruijun, ZHAO Meng, WANG Wenjuan, LU Jingjing, LI Na, LIU Yanfang, BIAN Liheng, YU Songlin, LI Hao, ZHANG Qian, WU Jianwei, WANG Dandan, WANG Jing, LI Zhaoxia, JIANG Ruixuan, KANG Kaijiang, XUE Yimeng, YA Xiaolong, HE Qiheng, MO Shaohua, ZHAO Xingquan, ZHAO Jizong, the Writing Committee of Chinese Stroke Association Guidelines for Clinical Management of Cerebrovascular Diseases ( Contributed equally).
Chinese Stroke Association Guidelines for Clinical Management of Cerebrovascular Diseases (Second Edition) (Excerpt) ——Chapter Five Clinical Management of Intracerebral Hemorrhage
[J]. Chinese Journal of Stroke, 2023, 18(9): 1014-1023.
|
[14] |
The Neurocritical Care Working Group of National Center for Healthcare Quality Management in Neurological Diseases.
Quality Control Indicators in Neurocritical Care
[J]. Chinese Journal of Stroke, 2023, 18(12): 1450-1455.
|
[15] |
ZHANG Linlin, ZHOU Jianxin.
Neurocritical Care Quality Control 2018—2023: From Resource Investigation to Quality Control Indicators
[J]. Chinese Journal of Stroke, 2023, 18(12): 1456-1459.
|